MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions

Completed · Not applicable

Conditions studied: Myelodysplastic Syndrome (MDS)

In brief

A known risk of red blood cell transfusions is that it puts excess iron into the patient's body. Researchers are continually seeking the most effective method of measuring iron concentration. The purpose of this study is to determine how much iron has been deposited in a patient's heart and liver as a result of having received red blood cell transfusions using magnetic resonance imaging (MRI).

Key facts

Study ID

NCT00749372

Run by

Weill Medical College of Cornell University

People needed

15

Starts

2008-07-31

Expected to finish

2013-03-29

Last updated by the study team

2018-10-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female patients will need documentation of diagnosis of Myelodysplastic Syndrome by previous bone marrow exam
• Male or female patients with MDS who have received at least 50 units of Red Blood Cell Transfusions.
• Serum ferritin > 1,000
• Written informed consent by the patient.

You may not qualify if…

• Contraindication to MRI, including cardiac pacemaker, brain aneurysm clip, implanted neurostimulator, insulin pump, cochlear implant, metal slivers in the eyes, intrauterine device or any other MRI incompatible metal implants or intractable claustrophobia.

Where it is running

• Weill Medical College of Cornell University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.